Biotech Values

[DewDiligence]

SNY Reports $4.1B of Annualized 1Q10 Lovenox Sales, 57% in US

[Sanofi’s reporting currency is the Euro, but the growth rates shown
below are in local currencies. Tallying growth in local currencies is a
way to track the change in volume and price irrespective of exchange
rates. The figures below are annualized, i.e. they are 4x the reported
1Q10 numbers.]


Worldwide Lovenox sales rose 5% YoY to an annualized rate of €3.08B, which is $4.1B at the current exchange rate.

US Lovenox sales were flat YoY at an annualized rate of €1.74B, which is $2.3B at the current exchange rate.

The breakdown of annualized 1Q10 Lovenox sales by geography is as follows; growth rates are year-over-year in local currencies:

US: €1.74B (57% of total), 0% growth
EU: €1.01B (33% of total), 15% growth
RoW: €328M (11% of total), 3% growth
=====
Total: €3.08B, 5% growth

Source: http://en.sanofi-aventis.com/binaries/20100429_q1_2010_en_tcm28-28188.pdf